Celularity Inc. Current Liabilities
Celularity Inc. (CELU) had Current Liabilities of $80.76 million as of 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-04-30
- 2025-12-31: Liabilities, Current $80.76M.
- 2025-09-30: Liabilities, Current $65.31M.
- 2025-06-30: Liabilities, Current $69.23M.
- 2025-03-31: Liabilities, Current $58.69M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2025-12-31 | $80.76M 10-K · filed 2026-04-30 | |
| 2025-09-30 | $65.31M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $69.23M 10-Q · filed 2025-08-29 | |
| 2025-03-31 | $58.69M 10-Q · filed 2025-08-29 | |
| 2024-12-31 | $53.68M 10-K · filed 2026-04-30 | |
| 2024-09-30 | $76.17M 10-Q · filed 2024-12-06 | |
| 2024-06-30 | $67.90M 10-Q · filed 2024-11-07 | |
| 2024-03-31 | $66.04M 10-Q · filed 2024-10-16 | |
| 2023-12-31 | $67.30M 10-K · filed 2025-05-08 | |
| 2023-09-30 | $84.63M 10-Q · filed 2024-01-03 | |
| 2023-06-30 | $64.98M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $66.46M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $62.09M 10-K · filed 2024-07-30 | |
| 2022-09-30 | $69.22M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $32.94M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $26.03M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $26.23M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $29.21M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $7.29M 10-Q · filed 2021-08-19 | |
| 2021-03-31 | $5.16M 10-Q · filed 2021-05-24 | |
| 2020-12-31 | $26.68M 10-K · filed 2022-03-31 | $3.41M 10-K · filed 2021-03-04 |
| 2020-09-30 | $141.31K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $152.61K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $128.70K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $229.09K 10-K/A · filed 2021-05-24 | |
| 2019-09-30 | $106.81K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $172.95K 10-Q · filed 2019-08-07 | |
| 2018-12-31 | $150.56K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |